The Indian Journal of Pediatrics

, Volume 61, Issue 2, pp 183–188 | Cite as

Simultaneous administration of Hepatitis B vaccine with other E.P.I. vaccines

  • S. K. Mittal
  • S. Rao
  • Sudarshan Kumari
  • Vyom Aggarwal
  • Charu Prakash
  • S. Thirupuram
Original Articles


Development of recombinant DNA vaccine against hepatitis B grown on cultured yeast cell has made it possible to mount a world-wide effort to control and eradicate Hepatitis B infection. However, the currently recommended schedules (0, 1 & 2 months, and 0–1 and 6 months) do not coincide with the scheduled visits for other E.P.I. vaccines, and necessitate additional visits for Hepatitis B vaccination. This study was therefore carried out to find out if adequate seroconversion occurs to Hepatitis B vaccine when given with other EPI vaccines or not?

Thirty nine infants born to Australia antigen positive mothers from among 850 screened pregnant mothers were recruited to receive Hepatitis B vaccine (Engerix B-10 micro gram each) at 0, 6 and 14 wks (group A) or at 0, 1 and 2 months (group B). Thirty-one infants were recruited in group A and 8 in group B. The cord blood was collected and the first dose of vaccine was given within 48 hours of birth. Simultaneous B.C.G. was given at the left deltoid. Other E.P.I. vaccines were given qt 6, 10 and 14 wks in group A and at 2, 3 and 4 months in group B. Repeat blood samples were collected prior to giving each dose of Hepatitis B vaccine, and 4 weeks after the last dose. All blood samples were assayed for HBsAg and HBsAb at the National Institute Of Communicable Diseases, utilizing standard ELISA kits.

The seroconversion rates following one, two and three doses of Hepatitis B vaccine were 3.33%, 55.5%, 96.15% and 0%, 62.5% and 100% in group A and B respectively. Only one infant in group A failed to develop HbsAb even after 3 doses of Hepatitis B vaccine, 5 infants in group A were available at 9 months of age and were still positive for HBsAb and negative for HBsAg. Recombinant DNA Hepatitis B vaccine (Engerix-B) is a highly effective vaccine which can safely and effectively be given together with other childhood vaccines.

Key words

Hepatitis B Vertical transmission Post exposure prophylaxis E.P.I. 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ghendon Y. WHO strategy for the global elimination of new cases of Hepatitis B.Vaccine 1990; 8 (Suppl): 129–132.Google Scholar
  2. 2.
    Hoofnagle JH. Towards universal immunisation against Hepatitis B virus.N Engl J Med 1989; 321: 1333–1334.PubMedCrossRefGoogle Scholar
  3. 3.
    Maynard JE, Hepatitis B: Global importance and need for control.Vaccine 1990; 8 (Suppl. 1): 18–20.CrossRefGoogle Scholar
  4. 4.
    Sobeslavsky O. Prevalence of markers of Hepatitis B virus infection in various countries: A WHO collaborative study.Bull WHO 1980; 58: 621–628.PubMedGoogle Scholar
  5. 5.
    Sung JL. Hepatitis B virus eradication strategy for Asia.Vaccine 1990; 8 (Suppl): 95–98.Google Scholar
  6. 6.
    West DJ, Calandra GB, Ellis RW. Vaccination of infants and children against Hepatitis B.Pediatr Clin North Am 1990; 37: 585–603.PubMedGoogle Scholar
  7. 7.
    Yeoh EK. Hepatitis B virus infection in children.Vaccine 1990; 8 (Suppl): 29–30.CrossRefGoogle Scholar
  8. 8.
    Andre FE, Safary A. Summary of clinical findings on Engerix B, a genetically engineered yeast derived Hepatitis B vaccine.Post Grad Med J 1987; 63 (2): 169–178.Google Scholar
  9. 9.
    Centres for Diseases Control. Update on Hepatitis B prevention. Recommendations of the immunization practices advisory committee.Ann Intern Med 1987; 107: 353–357.Google Scholar
  10. 10.
    Maynard JE, Kane MA, Hadler SC. Global control of Hepatitis B through vaccination—Role of Hepatitis B vaccine in EPI.Rev Infect Dis 1989; 11 (Suppl 3): 574–578.Google Scholar
  11. 11.
    Expanded Programme on Immunization Cost-effectiveness.Weekly Epidemiology Record 1982; 22: 170–172.Google Scholar
  12. 12.
    Guha DK, Mahajan J, Aggarwal SK et al. Vertical transmission of Hepatitis B virus.Indian Pediatr 1988; 25: 409–416.PubMedGoogle Scholar
  13. 13.
    Gupta I, Sehgal A, Bhakoo DN et al. Immunoprophylaxis of neonates born to Hepatitis B surface antigen positive pregnant women. Proceedings “Update in Viral Hepatitis” 1990; 137–143.Google Scholar
  14. 14.
    Gupta ML, Sharma U, Saxena S et al. Vertical transmission of Hepatitis B. Surface antigen from asymptomatic carrier mothers.Indian Pediatr 1985; 22: 339–342.PubMedGoogle Scholar
  15. 15.
    Kane MA, Hadler SC, Marglis HS et al. Routine prenatal screening for Hepatitis B surface antigen.JAMA 1988; 259: 408–409.PubMedCrossRefGoogle Scholar
  16. 16.
    Bortolotti F, Cadrobbi P, Crivellaro et al. Long term outcome of chronic type B Hepatitis in patients who acquire Hepatitis B virus infection in childhood.Gastroenterology 1990; 99: 805–810.PubMedGoogle Scholar
  17. 17.
    Cadranel S, Zeghlache S, Fernandes S et al. Vaccination of newborns of HBsAg positive carrier mothers with a recombinant DNA Hepatitis B caccine.Post Grad Med J 1987; 63 (Suppl 2): 159–160.Google Scholar
  18. 18.
    Hollinger FB, Troisi CL, Pepe PE. Anti HBs responses to vaccination with a human Hepatitis B vaccine made by recombinant DNA technology in yeast.J Infect Dis 1986; 153: 156–159.PubMedGoogle Scholar
  19. 19.
    Memorandum from a WHO meeting. Progress in control of viral Hepatitis.Bull WHO 1988; 66: 443–455.Google Scholar
  20. 20.
    Piazza M, Villari R, Orlando R et al. Hepatitis B immunisation with a reduced number of doses in newborn babies and children.Lancet 1985; ii: 949–952.CrossRefGoogle Scholar
  21. 21.
    Zachoval R, Jilg W, Lorbeer B et al. Passive-active immunisation against Hepatitis B.J Infect Dis 1984; 150: 112–117.PubMedGoogle Scholar
  22. 22.
    Coursaget P, Relyveld EH, Barres JL et al. Simultaneous administration of Hepatitis B vaccine and DPT-polio vaccine.Infection and Immunity 1986; 51: 784–787.PubMedGoogle Scholar
  23. 23.
    Chiron JP, Coursaget P, Yvomet B et al. Simultaneous administration of Hepatitis B and diphtheria, tetanus, polio vaccine.Lancet 1984; 1: 623–624.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1994

Authors and Affiliations

  • S. K. Mittal
    • 2
  • S. Rao
    • 2
  • Sudarshan Kumari
    • 1
  • Vyom Aggarwal
    • 2
  • Charu Prakash
    • 1
  • S. Thirupuram
    • 2
  1. 1.National Institute of Communicable DiseasesDelhi
  2. 2.Department of PediatricsMaulana Azad Medical CollegeNew Delhi

Personalised recommendations